Format

Send to

Choose Destination
Kidney Int Suppl. 2000 Sep;77:S53-8.

Mechanism of transforming growth factor-beta1 signaling:.

Author information

1
Department of Internal Medicine, Yale University School of Medicine, and the Veterans Affairs Connecticut Healthcare Systems, New Haven 06520-8029, USA. mary.choi@yale.edu

Abstract

Mechanism of transforming growth factor-beta1 signaling: Role of the mitogen-activated protein kinase. Transforming growth factor-beta1 (TGF-beta1) regulates diverse biologic activities including cell growth, cell death or apoptosis, cell differentiation, and extracellular matrix (ECM) synthesis. TGF-beta1 is believed to be a key mediator of tissue fibrosis as a consequence of ECM accumulation in pathologic states such as progressive renal diseases including diabetic nephropathy. TGF-beta1 actions are mediated by the heteromeric interactions of types I and II serine/threonine kinase receptors. Initiation of signaling requires binding of TGF-beta1 to TGF-beta type II receptor (TbetaR-II), a constitutively active serine/threonine kinase, which subsequently transphosphorylates TGF-beta type I receptor (TbetaR-I). However, the signaling pathway following the initial receptor interaction with ligand remains poorly understood. Much of current investigation, including in our laboratory, is now focused on the elucidation of the intracellular signaling components that mediate TGF-beta1 signals downstream of the cell-surface receptors. An emerging body of evidence implicates the mitogen-activated protein kinase (MAPK) as an important TGF-beta1 signaling pathway.

PMID:
10997691
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center